Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Domino's sees 2025 sales up as FY profits rise on value offers

(Sharecast News) - Domino's Pizza delivered a 3.8% rise in underlying core earnings as customers tucked into special offers in store and online. The fast-food chain said underlying earnings before interest, taxes, depreciation and amortisation came in at £143.4m in the year to December 29 compared to a 53-week trading year in 2023.

"Although the UK economic environment remains uncertain, in the first 10 weeks of the year, our growth has been positive with total system sales up 2.4%, total orders +0.7% and like-for-like sales +0.7%," the company said on Tuesday.

"In the current environment we see an opportunity to drive further growth in collection orders in 2025 through value-based marketing campaigns."

"Our brand and market positioning continues to strengthen and we have a number of initiatives, from the next phase of our loyalty trial to exciting menu innovation, which will improve our customer proposition and drive growth in the system."

Domino's is targeting more than 1,600 stores delivering £2bn of systems sales by 2028 and 2,000 stores delivering £2.5bn of system sales by 2033.

The company held guidance for the current fiscal year and also named Ian Bull as its new chair, replacing Matt Shattock.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.